| Event Details |
| 3rd Annual UCHMC Research Symposium |
| 09/06 - 09/07/2018 |
| University of California, Irvine |
| Irvine, California |
| United States |
3rd Annual UCHMC Research Symposium
The University of California Hematologic Malignancies Consortium (UCHMC) is a collaboration across the 5 University of California Cancer Centers to conduct multicenter investigator initiated clinical trials in a more efficient and effective manner. The annual UCHMC research symposium is formatted to highlight the research being conducted across the UC system.
The 3rd Annual UCHMC Research Symposium will include discussions on opportunities for collaboration across the UC system, translating recent laboratory discoveries into new therapies, application of novel therapies in hematologic malignancies, and ongoing clinical trials currently being conducted by the UC Hematologic Malignancies Consortium.
The research symposium will provide attendees with information regarding current research in the field and application of novel therapies allowing those in attendance to better serve their patient population.
The objectives of this meeting are to gain an understanding of how basic research discoveries are being translated into clinical trials, gain a better understanding of best practice in the management of hematologic malignancies and to become familiar with targeted and immunotherapeutic approaches for the treatment of hematologic malignancies.
Thursday September 6, 2018 (9:30AM-4:00PM): Disease team meetings will be held throughout the day and will consist of a 45 minute closed session for members of the UC community and 15 minutes at the end of each meeting for discussion and input by industry attendees. No CME Credits offered for attendance on Thursday September 6, 2018.
Sprague Hall
839 Medical Sciences Court, Sprague Hall
Irvine, CA 92697
Friday September 7, 2018 (7:30AM-7:30PM): Presentations from members of the UC community will be held throughout the day. Light breakfast, coffee service and lunch will be provided to all attendees. CME Credits available.
Gross Hall: A CIRM Institute
845 Health Sciences Road
Irvine, CA 92697
The meeting will conclude with a networking cocktail hour and poster session on Friday September 7th,2018
For Additional Information, please visit www.UCHMC.org
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of California, Irvine School of Medicine and the University of California Hematologic Malignancies Consortium. The University of California, Irvine School of Medicine is accredited by the ACCME to provide continuing medical education for physicians
Designation Statement
The Unviersity of California, Irvine School of Medicine designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
We look forward to your participation in our 3rd Annual UCHMC Research Symposium.
